Udemy Inc (UDMY) Director Eren Bali Sells 15,000 Shares

Eren Bali, Director of Udemy Inc (NASDAQ:UDMY), executed a sale of 15,000 shares in the company on April 1, 2024, according to a recent SEC filing. The transaction was disclosed in a Form 4 filing with the Securities and Exchange Commission.Udemy Inc is an online learning platform that offers a vast array of courses covering various subjects such as business, technology, and personal development. The platform allows experts to create and share paid courses, providing a diverse learning ecosystem for users worldwide.Over the past year, the insider has sold a total of 169,188 shares of Udemy Inc and has not made any purchases of the stock. The recent sale of 15,000 shares is part of this ongoing pattern of insider transactions.The insider transaction history for Udemy Inc reveals a trend of more insider sales than purchases over the past year. There have been 2 insider buys and 56 insider sells during this period.On the date of the reported sale, shares of Udemy Inc were trading at $10.96 each, which places the company's market cap at approximately $1.702 billion.

The insider's recent transaction follows the broader insider selling trend at Udemy Inc and provides investors with information on insider sentiment. However, it is important to consider the full range of factors affecting the stock's performance and not solely insider transactions when making investment decisions.

• Warning! GuruFocus has detected 6 Warning Signs with MSTR.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.